SPINK9: A selective, skin-specific kazal-type serine protease inhibitor

Journal of Investigative Dermatology

Volumn 129, Issue 7, 2009, Pages 1656-1665

  Brattsand, Maria ^a   Stefansson, Kristina ^a   Hubiche, Thomas ^a   Nilsson, Stefan K ^a   Egelrud, Torbjörn ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN; CHYMOTRYPSIN; COMPLEMENTARY DNA; FIBRINOGEN; KALLIKREIN 5; KALLIKREIN INHIBITOR; NEUROPSIN; PROTEIN SPINK 9; RNA; STRATUM CORNEUM CHYMOTRYPTIC ENZYME; THROMBIN; TRYPSIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL STRAIN; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MASS SPECTROMETRY; MOLECULAR CLONING; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; STRATUM CORNEUM; SURFACE PLASMON RESONANCE; TISSUE DISTRIBUTION; TISSUE SPECIFICITY;

EID: 67449159025     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.448     Document Type: Article

References (42)

1. Borgoño C, Michael I, Diamandis E (2004) Human tissue kallikreins: physiologic roles and applications in cancer. Mol Cancer Res 2: 257-80
2. Brattsand M, Egelrud T (1999) Purification, molecular cloning, and expression of a human stratum corneum trypsin-like serine protease with possible function in desquamation. J Biol Chem 274:30033-40
3. Brattsand M, Stefansson K, Lundh C, Haasum Y, Egelrud T (2005) A proteolytic cascade of kallikreins in the stratum corneum. J Invest Dermatol 124:198-203
4. Caubet C, Jonca N, Brattsand M, Guerrin M, Bernard D, Schmidt R et al. (2004) Degradation of comeodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J Invest Dermatol 122:1235-44
5. Chavanas S, Bodemer C, Rochat A, Hamel-Teillac D, Ali M, Irvine A et al. (2000) Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 25:141-2
6. Chen J, Mercier B, Audrezet M, Ferec C (2000) Mutational analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene in hereditary and sporadic chronic pancreatitis. J Med Genet 37:67-9
7. Clements J, Willemsen N, Myers S, Dong Y (2004) The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers. Crit Rev Clin Lab Sci 41:265-312
8. Deraison C, Bonnart C, Lopez F, Besson C, Robinson R, Jayakumar A et al. (2007) LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent Interaction. Mol Biol Cell 18:3607-19
9. Descargues P, Deraison C, Bonnart C, Kreft M, Kishibe M, Ishida-Yamamoto A et al. (2005) Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat Genet 37:56-65
10. Egelrud T (1993) Purification and preliminary characterization of stratum corneum chymotryptic enzyme: a proteinase that may be involved in desquamation. J Invest Dermatol 101:200-4
11. Ekholm I, Brattsand M, Egelrud T (2000) Stratum corneum tryptic enzyme in normal epidermis: a missing link in the desquamation process? J Invest Dermatol 114:56-63
12. Galante P, Sakabe N, Kirschbaum-Slager N, de Souza S (2004) Detection and evaluation of intron retention events in the human transcriptome. RNA 10:757-65
13. Hachem J, Wagberg F, Schmuth M, Crumrine D, Lissens W, Jayakumar A et al. (2006) Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome. J Invest Dermatol 126:1609-21
14. Hansson L, Strömqvist M, Bäckman A, Wallbrandt P, Carlstein A, Egelrud T (1994) Cloning, expression, and characterization of stratum corneum chymotryptic enzyme. A skin-specific human serine proteinase. J Biol Chem 269:19420-6
15. Harvey T, Hooper J, Myers S, Stephenson S, Ashworth L, Clements J (2000) Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4. J Biol Chem 275:37397-406
16. Hughes T (2006) Regulation of gene expression by alternative untranslated regions. Trends Genet 22:119-22
17. Kaifi J, Rawnaq T, Schurr P, Yekebas E, Mann O, Merkert P et al. (2007) Short tandem repeat polymorphism in exon 4 of esophageal cancer-related gene 2 detected in genomic DNA is a prognostic marker for esophageal cancer. Am J Surg 194:380-4
18. Komatsu N, Takata M, Otsuki N, Ohka R, Amano O, Takehara K et al. (2002) Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides. J Invest Dermatol 118:436-43
19. Komatsu N, Takata M, Otsuki N, Toyama T, Ohka R, Takehara K et al. (2003) Expression and localization of tissue kallikrein mRNAs in human epidermis and appendages. J Invest Dermatol 121:542-9
20. Laskowski MJ, Kato I (1980) Protein inhibitors of proteinases. Annu Rev Biochem 49:593-626
21. Lundwall A, Band V, Blaber M, Clements J, Courty Y, Diamandis E et al. (2006) A comprehensive nomenclature for serine proteases with homology to tissue kallikreins. Biol Chem 387:637-41
22. Matsudaira P (1987) Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J Biol Chem 262:10035-8
23. Mägert H, Ständker L, Kreutzmann P, Zucht H, Reinecke M, Sommerhoff C et al. (1999) LEKTI, a novel 15-domain type of human serine proteinase inhibitor. J Biol Chem 274:21499-502
24. Ny A, Egelrud T (2004) Epidermal hyperproliferation and decreased skin barrier function in mice overexpressing stratum corneum chymotryptic enzyme. Acta Derm Venereol 84:18-22
25. Oikonomopoulou K, Hansen K, Saifeddine M, Vergnolle N, Tea I, Blaber M et al. (2006) Kallikrein-mediated cell signalling: targeting proteinaseactivated receptors (PARs). Biol Chem 387:81 7-24
26. Rockett J, Patrizio P, Schmid J, Hecht N, Dix D (2004) Gene expression patterns associated with infertility in humans and rodent models. Mutat Res 549:225-40
27. Schechter N, Choi E, Wang Z, Hanakawa Y, Stanley J, Kang Y et al. (2005) Inhibition of human kallikreins 5 and 7 by the serine protease inhibitor lympho-epithelial Kazal-type inhibitor (LEKTI). Biol Chem 386: 1173-84
28. Serre G, Mils V, Haftek M, Vincent C, Croute F, Réano A et al. (1991) Identification of late differentiation antigens of human comified epithelia, expressed in re-organized desmosomes and bound to crosslinked envelope. J Invest Dermatol 97:1061-72
29. Skerrow C, Clelland D, Skerrow D (1989) Changes to desmosomal antigens and lectin-binding sites during differentiation in normal human epidermis: a quantitative ultrastructural study. J Cell Sci 92(Part 4):667-77
30. Smith D, Smith J, Wong S, deShazo R (1995) Netherton's syndrome: a syndrome of elevated IgE and characteristic skin and hair findings. J Allergy Clin Immunol 95:116-23
31. Sprecher E, Chavanas S, DiGiovanna J, Amin S, Nielsen K, Prendiville J et al. (2001) The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis. J Invest Dermatol 117:179-87
32. Stefansson K, Brattsand M, Ny A, Glas B, Egelrud T (2006) Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum. Biol Chem 387:761-8
33. Stefansson K, Brattsand M, Roosterman D, Kempkes C, Bocheva G, Steinhoff M et al. (2008) Activation of proteinase-activated receptor-2 by human kallikrein-related peptidases. J Invest Dermatol 128:18-25
34. Walley A, Chavanas S, Moffatt M, Esnouf R, Ubhi B, Lawrence R et al. (2001 ) Gene polymorphism in Netherton and common atopic disease. Nat Genet 29:175-8
35. Watkinson A, Harding C, Moore A, Coan P (2001) Water modulation of stratum corneum chymotryptic enzyme activity and desquamation. Arch Dermatol Res 293:470-6
36. Witt H, Luck W, Hennies H, Classen M, Kage A, Lass U et al. (2000) Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 25:213-6
37. Wu Z, Bartels J, Schröder J (2008) Lympho-epithelial-Kazal-type- inhibitor (LEKTI)2: a novel epithelial peptide antibiotic. J Investig Dermatol 128:S178
38. Yamasaki K, Schauber J, Coda A, Lin H, Dorschner R, Schechter N et al. (2006) Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J 20:2068-80
39. Yang T, Liang D, Koch P, Hohl D, Kheradmand F, Overbeek P (2004) Epidermal detachment, desmosomal dissociation, and destabilization of comeodesmosin in Spink5-/- mice. Genes Dev 18:2354-8
40. Yoon H, Laxmikanthan G, Lee J, Blaber S, Rodriguez A, Kogot J et al. (2007) Activation profiles and regulatory cascades of the human kallikreinrelated peptidases. J Biol Chem 282:31852-64
41. Yousef G, Luo L, Diamandis E (1999) Identification of novel human kallikreinlike genes on chromosome 19q13.3-q13.4. Anticancer Res 19:2843-52
42. Yue C, Bi M, Tan W, Deng D, Zhang X, Guo L et al. (2004) Short tandem repeat polymorphism in a novel esophageal cancer-related gene (ECRG2) implicates susceptibility to esophageal cancer in Chinese population. Int J Cancer 106:232-6